// App-Quantinova.ai

163 2016 ATVB : Apabetalone (RVX-208) Has Anti-atherosclerotic, Anti-Thrombotic and Anti-Inflammatory Effects in Patients With Cardiovascular Disease (CVD)

Researchers

Presenter

  • Sylwia Wasiak

Principal Investigators

  • Dean Gilham

  • Cyrus Calosing

  • Laura Tsujikawa

  • Christopher Halliday

  • Resverlogix Corp

  • Jan Johansson

  • Mike Sweeney

  • Norman C Wong

Medical Centers

  • Health Science Ctr., Calgary, AB, Canada

  • Uni, Calgary, AB, Canada

Locations

  • Canada

Companies

  • Resverlogix Corp.

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

Biomarkers

  • C-C Motif Chemokine Ligand 2

  • Apolipoprotein A-I

  • C-C Motif Chemokine Ligand 18

  • Peripheral blood mononuclear cell

  • C-C Motif Chemokine Ligand 5

  • Cytokine

  • Trimethylamine-N-oxide

Drug/Treatment

  • RVX-208

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved